Industry Guide · Pharmaceuticals & Biotechnology

Pharmaceuticals & Biotechnology Quality Control Software

Pharmaceutical and biotechnology manufacturers operate under the most stringent regulatory framework in life sciences. Compliance with FDA 21 CFR Part 11 (electronic records and electronic signatures), 21 CFR Part 210/211 (cGMP), ICH Q7/Q9/Q10, EU GMP Annex 11, and global GxP (GMP, GLP, GCP) regulations demands validated electronic systems for document control, electronic batch records (EBR), deviation management, change control, and audit trail integrity. The right pharmaceutical QMS replaces paper-based batch records with electronic batch records (EBR/EBRS), automates deviation and CAPA workflows, enforces ALCOA+ data integrity principles, and maintains continuous audit readiness for FDA, EMA, MHRA, and PMDA inspections. MasterControl, MasterControl Quality Excellence, Veeva Vault QMS, TrackWise, and other GxP-validated platforms dominate this space because they deliver out-of-the-box validation packages, 21 CFR Part 11 compliant audit trails, electronic signatures with biometric/credential-based authentication, and pre-validated CSV (Computer System Validation) documentation packages that accelerate time-to-validation.

Key Challenges

FDA 21 CFR Part 11 compliance: validated audit trails, electronic signatures, system access controls, and operational/technical controls per 21 CFR 11.10/11.30/11.50/11.70/11.100/11.200
GxP document control: controlled document lifecycle (draft → review → approve → distribute → obsolete) with version control, electronic signatures, and complete audit trails per ICH Q10 / EU GMP Annex 11
Electronic Batch Records (EBR/EBRS): paperless manufacturing execution, real-time data capture from PLCs/DCS/MES, electronic signatures at each step, automatic calculations, and parametric release
ALCOA+ / ALCOA++ data integrity: Attributable, Legible, Contemporaneous, Original, Accurate — plus Complete, Consistent, Enduring, Available across all GxP systems
Computer System Validation (CSV) / CSA (Computer Software Assurance) per GAMP 5: risk-based validation, IQ/OQ/PQ protocols, traceability matrices, and periodic review
Deviation / Non-conformance / CAPA management: 21 CFR 211.192 / ICH Q10 / EU GMP Ch. 8 workflows with root cause analysis (5 Why, Fishbone, FTA), effectiveness checks, and regulatory reportability assessment (MDR, FDA MDR/eMDR, Field Alert Reports)
Change Control: 21 CFR 211.160 / ICH Q10 / EU GMP Ch. 5 — impact assessment, classification (minor/major/critical), regulatory filing assessment (PAS, CBE-30, CBE-0), and cross-functional approval routing
Supplier Quality Management: 21 CFR 211.84 / 211.110 / ICH Q7 / EU GMP Ch. 7 — supplier qualification, audit management, incoming material testing, and quality agreements
Training Management: 21 CFR 211.25 / EU GMP Ch. 2 — role-based training assignment, read-and-understand tracking, effectiveness verification, and GxP training compliance reporting
Audit Readiness & Inspection Management: FDA PAI (Pre-Approval Inspection), EMA/MHRA/PMDA inspections — inspection readiness dashboards, document request lists (DRL), and war room preparation
Electronic Signature & Audit Trail Integrity: 21 CFR 11.50/11.70/11.100/11.200 — unique user IDs, biometric/credential-based signatures, meaning of signature, signature manifestation, and tamper-evident audit trails
MasterControl / Veeva Vault / TrackWise / MasterControl Quality Excellence alignment: validation packs, CSV deliverables, IQ/OQ/PQ scripts, traceability matrices, and periodic review templates
Continuous Process Verification (CPV) & Real-Time Release Testing (RTRT): ICH Q8/Q9/Q10 / PAT (Process Analytical Technology) integration with MES/LIMS
Data Migration & Legacy System Retirement: 21 CFR 11.10 / EU Annex 11 compliant migration, dual-running, reconciliation, and validated archival

Applicable Standards

FDA 21 CFR Part 11 (Electronic Records & Electronic Signatures)
FDA 21 CFR Part 210/211 (cGMP for Finished Pharmaceuticals)
FDA 21 CFR Part 820 (QSR — for combination products)
ICH Q7 (GMP for Active Pharmaceutical Ingredients)
ICH Q9 (Quality Risk Management)
ICH Q10 (Pharmaceutical Quality System)
EU GMP Annex 11 (Computerised Systems)
EU GMP Annex 1 (Sterile Products — Contamination Control Strategy)
PIC/S GMP Guide (Pharmaceutical Inspection Co-operation Scheme)
WHO GMP (World Health Organization)
21 CFR Part 58 (GLP — Good Laboratory Practice)
21 CFR Part 312 / ICH E6 (GCP — Good Clinical Practice)
21 CFR Part 58 / OECD GLP (Non-clinical Lab Studies)
FDA Data Integrity Guidance (ALCOA+ / ALCOA++)
FDA 21 CFR Part 11 Audit Trail Requirements (21 CFR 11.10, 11.30, 11.50, 11.70)
ISPE GAMP 5 (Good Automated Manufacturing Practice)
21 CFR Part 11 Electronic Signature Requirements (11.50, 11.70, 11.100, 11.200)
EU Annex 11 Audit Trail & Electronic Signature Requirements
MHRA GxP Data Integrity Guidance (2018/2021)
PIC/S PI 041-1 (Data Integrity)
WHO TRS 996 Annex 5 (Data Integrity)
FDA 21 CFR Part 211.180/186/188/192/194 (Batch Records, Deviation, OOS, Change Control)

Must-Have Features for Pharmaceuticals & Biotechnology

When evaluating quality software for pharmaceuticals & biotechnology, prioritize these capabilities:

FDA 21 CFR Part 11 validated audit trail (immutable, time-stamped, user-attributed)
Electronic signatures per 21 CFR 11.50/11.70/11.100/11.200 (credential + biometric)
Electronic Batch Records (EBR/EBRS) with MES/DCS/PLC integration
GxP Document Control (SOPs, protocols, reports, specs) with version control & e-signatures
Deviation / Non-conformance / CAPA workflows (21 CFR 211.192, ICH Q10, EU GMP Ch. 8)
Change Control with regulatory filing impact assessment (PAS, CBE-30, CBE-0)
Computer System Validation (CSV) / CSA packs per GAMP 5 (IQ/OQ/PQ scripts, trace matrix)
Supplier Quality Management (qualification, audits, incoming inspection, quality agreements)
Training Management (role-based, read-and-understand, effectiveness, GxP compliance)
Audit Management (scheduling, checklists, findings, CAPA linkage, inspection readiness)
Equipment & Calibration Management (21 CFR 211.160/180, EU GMP Ch. 3/4)
Environmental Monitoring & Trending (EU Annex 1 contamination control strategy)
OOS / OOT Investigation Workflows (21 CFR 211.192, FDA OOS Guidance)
Periodic Product Quality Review (PQR/APR) automation (ICH Q10, EU GMP Ch. 1)
Regulatory Submission Publishing (eCTD, NeeS, FDA eSubmitter)
MasterControl / Veeva Vault / TrackWise / ValGenesis migration & validation packs
ALCOA+ / ALCOA++ data integrity enforcement across all GxP records
Electronic Logbooks (equipment, cleaning, maintenance, environmental)
Risk Management (ICH Q9 / ISO 14971) integrated with CAPA/Change/Deviation
Continuous Process Verification (CPV) & Real-Time Release (RTRT) analytics
21 CFR Part 11 / EU Annex 11 validated cloud deployment (AWS GovCloud, Azure Gov, GCP Assured Workloads)
Single Sign-On (SSO/SAML/OIDC) with 21 CFR Part 11 compliant identity management
Role-Based Access Control (RBAC) with least privilege per 21 CFR 11.10
Periodic Review & Trending (product quality, complaints, deviations, changes)
Customer Complaint Handling (21 CFR 211.198, EU GMP Ch. 8) with MDR/eMDR assessment

Recommended Vendors for Pharmaceuticals & Biotechnology

These vendors serve the pharmaceuticals & biotechnology industry and support relevant standards.

Vendor	Best For	Deployment	Starting Price	Sandbox / POC
Minitab Statistical Software Visit Website →	Quality engineers needing validated statistical analysis & SPC per ISO 22514	cloud, on-premise	From $49/user/month (cloud)	Yes

Compare All Quality Control Software Vendors

See how every vendor stacks up in our detailed feature comparison matrix.

How much does quality control software cost?

How much does quality control software cost? See real per-user pricing, implementation fees, and total cost of ownership across every major vendor.

See Pricing Guide

Per-user SaaS pricingEnterprise license costsHidden fees & implementationROI benchmarks

View Full Comparison

Get Pharmaceuticals & Biotechnology Industry Updates

Subscribe for guides and vendor comparisons tailored to pharmaceuticals & biotechnology.